Schedule 13G ownership disclosure

Beta Bionics Inc

Common Stock, par value $0.0001 per share · CUSIP: 08659B102

Event date: 2026-02-18

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Point72 Asset Management, L.P.

    Shares: 2,290,023.00 · Class: 5.2%

  • Point72 Capital Advisors, Inc.

    Shares: 2,290,023.00 · Class: 5.2%

  • Steven A. Cohen

    Shares: 2,290,023.00 · Class: 5.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-26-001244
Form type
SCHEDULE 13G
Filer
Beta Bionics, Inc.
CIK
CIK 1674632
Filed
Feb 23, 2026
Reporting period
Feb 18, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub